Results 231 to 240 of about 156,767 (359)

Catabolism of tissue-type plasminogen activator by the human hepatoma cell line Hep G2

, 1989
Phillip A. Morton, D. Owensby, Burton E. Sobel, Alan L. Schwartz   +3 more
openalex   +1 more source

Proteomics Reveals Increased Periostin in Synovial Fluid From Canine and Human Anterior Cruciate Ligament Injury

Journal of Orthopaedic Research, Volume 43, Issue 7, Page 1239-1249, July 2025.
ABSTRACT Posttraumatic osteoarthritis (PTOA) is a common sequela to anterior cruciate ligament (ACL) injury in humans and dogs. Identification of conserved targets between species may hasten biomarker identification and therapeutic development. To identify differentially regulated synovial fluid (SF) proteins in ACL injury, SF samples were collected ...
Sydney J. Womack, Camila B. Carballo, Erica J. Secor, Scott A. Rodeo, Heidi L. Reesink   +4 more
wiley   +1 more source

Synergistic effects of neuroprotective drugs with intravenous recombinant tissue plasminogen activator in acute ischemic stroke: A Bayesian network meta-analysis. [PDF]

PLoS One
Dang C, Wang Q, Zhuang Y, Li Q, Lu Y, Xiong Y, Feng L.   +6 more
europepmc   +1 more source

Enhanced fibrinolysis caused by tissue plasminogen activator release in hemodialysis

, 1987
Wolfgang Speiser, Johann Wojta, C Korninger, Johannes C. KirchheimerJan Zazgornik, Bernd R. Binder   +4 more
openalex   +1 more source

Obesity Biomarkers: Exploring Factors, Ramification, Machine Learning, and AI‐Unveiling Insights in Health Research

MedComm, Volume 6, Issue 7, July 2025.
The graphical abstract emphasizes the complex nature of obesity, focusing on the interaction of behavioral, sociodemographic, genetic, and biomarker factors. It illustrates how lifestyle habits, demographics, and genetic predispositions influence obesity risk.
Ankita Awari, Deepika Kaushik, Ashwani Kumar, Emel Oz, Kenan Çadırcı, Charles Brennan, Charalampos Proestos, Mukul Kumar, Fatih Oz   +8 more
wiley   +1 more source

Neutrophil migration participates in the side effect of recombinant human tissue plasminogen activator. [PDF]

CNS Neurosci Ther
Huang Y, Han Z, Shen T, Zheng Y, Yang Z, Fan J, Wang R, Yan F, Tao Z, Luo Y, Liu P.   +10 more
europepmc   +1 more source

Navigating infection by pathogenic spirochetes: The host‐bacteria interface at the atomic level

Protein Science, Volume 34, Issue 7, July 2025.
Abstract Pathogenic spirochetes bind and interact with various host structures and molecules throughout the course of infection. By utilizing their outer surface molecules, spirochetes can effectively modulate their dissemination, interact with immune system regulators, and select specific destination niches within the host.
Libor Hejduk, Norbert Müller, Adriana Rathner, Ján Štěrba, Shang‐Cheng Hung, Chia‐Lin Chyan, Ryan O. M. Rego, Martin Strnad   +7 more
wiley   +1 more source

Tissue Plasminogen Activator in Acute Cardiac Arrest. [PDF]

J Community Hosp Intern Med Perspect
Acharya I, DeBoer SR, Haas CJ.
europepmc   +1 more source

Inflammation in atherosclerotic cardiovascular disease: From diagnosis to treatment

European Journal of Clinical Investigation, Volume 55, Issue 7, July 2025.
Inflammation in atherosclerotic cardiovascular disease. Residual inflammatory risk (RIR), defined by high‐sensitive C‐reactive protein (hsCRP) concentration of ≥2 mg/L, represents a strong predictor of future atherosclerotic cardiovascular disease (ASCVD) events. Although increased hsCRP values ≥2 mg/L might be detected in every three out of five ASCVD
Natalie Arnold, Wolfgang Koenig
wiley   +1 more source

Using Rotational Thromboelastometry (ROTEM) to Evaluate Coagulation Status After Intrapleural Recombinant Tissue Plasminogen Activator (rtPA) Administration in Regional Anesthesia. [PDF]

Cureus
DeLeon A, Tureanu L, Vetter O, Liu T, Korula R, Garcia Tomas V, Asher Y.   +6 more
europepmc   +1 more source